ELMD vs. FONR, VANI, OM, SMLR, HYPR, MBTC, ECOR, EDAP, AXGN, and ZYXI
Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include FONAR (FONR), Vivani Medical (VANI), Outset Medical (OM), Semler Scientific (SMLR), Hyperfine (HYPR), Nocturne Acquisition (MBTC), electroCore (ECOR), Edap Tms (EDAP), AxoGen (AXGN), and Zynex (ZYXI). These companies are all part of the "electromedical equipment" industry.
FONAR (NASDAQ:FONR) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, community ranking, dividends, media sentiment, valuation and earnings.
FONAR has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500.
In the previous week, FONAR had 3 more articles in the media than Electromed. MarketBeat recorded 3 mentions for FONAR and 0 mentions for Electromed. Electromed's average media sentiment score of 0.49 beat FONAR's score of 0.00 indicating that FONAR is being referred to more favorably in the media.
FONAR received 160 more outperform votes than Electromed when rated by MarketBeat users. However, 81.82% of users gave Electromed an outperform vote while only 73.48% of users gave FONAR an outperform vote.
50.6% of FONAR shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 8.6% of FONAR shares are held by insiders. Comparatively, 12.7% of Electromed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
FONAR has a net margin of 12.63% compared to FONAR's net margin of 7.62%. FONAR's return on equity of 10.32% beat Electromed's return on equity.
FONAR has higher revenue and earnings than Electromed. FONAR is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.
Summary
FONAR beats Electromed on 9 of the 15 factors compared between the two stocks.
Get Electromed News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Electromed Competitors List
Related Companies and Tools